Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CTNS Protein, N-His-SUMO

Catalog #:   YHB04901 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O60931
Protein length: Ser22-Ser120
Overview

Catalog No.

YHB04901

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser22-Ser120

Predicted molecular weight

22.99 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O60931

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

CTNS, Cystinosin

Note

For research use only.

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human CTNS protein
References

The value of Korean, American, and Chinese ultrasound risk stratification systems combined with BRAF(V600E) mutation for detecting papillary thyroid carcinoma in cytologically indeterminate thyroid nodules., PMID:37940765

Omic Studies on In Vitro Cystinosis Model: siRNA-Mediated CTNS Gene Silencing in HK-2 Cells., PMID:37949358

Functional analysis of the CTNS gene exonic variants predicted to affect splicing., PMID:38009794

Single phage proteins sequester TIR- and cGAS-generated signaling molecules., PMID:38014003

Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis., PMID:38016974

Cystinosis: Status of research and treatment in India and the world., PMID:38018544

CARM1 drives mitophagy and autophagy flux during fasting-induced skeletal muscle atrophy., PMID:38018843

Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom., PMID:38031005

Studies with Human-Induced Pluripotent Stem Cells Reveal That CTNS Mutations Can Alter Renal Proximal Tubule Differentiation., PMID:38069326

Event-related potential (ERP) evidence for visual processing differences in children and adults with cystinosis (CTNS gene mutations)., PMID:38087330

Neurologic involvement in cystinosis: Focus on brain lesions and new evidence of four-repeat (4R-) Tau immunoreactivity., PMID:38101161

Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides., PMID:38103556

Extrarenal complications of cystinosis., PMID:38127152

Cardiac troponins and coronary artery calcium score: a systematic review., PMID:38336618

Gene editing improves endoplasmic reticulum-mitochondrial contacts and unfolded protein response in Friedreich's ataxia iPSC-derived neurons., PMID:38420191

Lysosomal cystine accumulation activates mTOR signaling in cystinosis: are mTOR inhibitors the cure?, PMID:38519228

MFSD12 depletion reduces cystine accumulation without improvement in proximal tubular function in experimental models for cystinosis., PMID:38545650

Residual Cystine Transport Activity for Specific Infantile and Juvenile CTNS Mutations in a PTEC-Based Addback Model., PMID:38607085

Nlrp2 deletion ameliorates kidney damage in a mouse model of cystinosis., PMID:38633264

Cortical impairment and reduced muscle mass in children and young adults with nephropathic cystinosis., PMID:38864569

Associations Between Biomarkers of Myocardial Injury and Systemic Inflammation and Risk of Incident Ventricular Arrhythmia., PMID:38904572

Feedforward cysteine regulation maintains melanoma differentiation state and limits metastatic spread., PMID:38990725

Cystinosis-Associated Metabolic Bone Disease Across Ages and CKD Stages 1 to 5D/T., PMID:39049782

Long-term effects of luteolin in a mouse model of nephropathic cystinosis., PMID:39096619

Implications of Age for the Diagnostic and Prognostic Value of Cardiac Troponin T and I., PMID:39119905

Leptin signalling altered in infantile nephropathic cystinosis-related bone disorder., PMID:39210624

A systematic review and meta-analysis evaluating the association of high sensitivity troponin levels with outcomes in patients with stable coronary artery disease., PMID:39235073

Molecular characterization of clinically isolated Pseudomonas aeruginosa with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021., PMID:39254297

Severe pancytopenia at the presentation of Imerslund-Gräsbeck syndrome in a 23-month-old Italian boy., PMID:39294696

Mitigative role of cysteamine against unilateral renal reperfusion injury in Wistar rats., PMID:39372204

Reconstitution of Rab11-FIP4 Expression Rescues Cellular Homeostasis in Cystinosis., PMID:39434668

Single phage proteins sequester signals from TIR and cGAS-like enzymes., PMID:39478223

The Value of Biomarkers in Major Cardiovascular Surgery Necessitating Cardiopulmonary Bypass., PMID:39484111

ZenoSWATH DIA proteomics and clustering analysis of the effect of cysteamine at the cellular level in cystinotic fibroblasts., PMID:39504626

Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis., PMID:39530101

Cystinosis metabolic bone disease: inflammatory profile in human peripheral blood mononuclear cells and derived osteoclasts., PMID:39540998

An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients., PMID:39618989

Lysosomal reduced thiols are essential for mouse embryonic development., PMID:39764028

Nexinhib20 inhibits JFC1-mediated mobilization of a subset of CD11b/CD18+ vesicles decreasing integrin avidity, but does not inhibit Rac1., PMID:39883854

Targeting oxidative stress-induced lipid peroxidation enhances podocyte function in cystinosis., PMID:39980044

Cystinosin is involved in Na+/H+ Exchanger 3 trafficking in the proximal tubular cells: new insights in the renal Fanconi syndrome in cystinosis., PMID:39990449

Novel mechanism for tubular injury in nephropathic cystinosis., PMID:40111391

Transplantation of Wild-Type Hematopoietic Stem and Progenitor Cells Improves Disease Phenotypes in a Mucopolysaccharidosis IIIC Mouse Model., PMID:40126917

Inhibition of Tyrosinase and Melanogenesis by Carboxylic Acids: Mechanistic Insights and Safety Evaluation., PMID:40286213

Long-term outcomes in nephropathic cystinosis: a review., PMID:40369127

Computational prediction of deleterious nonsynonymous SNPs in the CTNS gene: implications for cystinosis., PMID:40375073

Untangling Traffic Jams: RAB11FIP4 Orchestrates Cellular Recovery in Cystinosis., PMID:40395987

Emerging therapeutic strategies for cystinosis., PMID:40469087

Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress., PMID:40505348

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CTNS Protein, N-His-SUMO [YHB04901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only